Prostate Cancer - Results from #22040

Utility of ADC measurement on diffusion-weighted MRI in differentiation of prostate cancer, normal prostate and prostatitis - Abstract October 15, 2013

The utility of PSA velocity in prediction of prostate cancer and high grade cancer after an initially negative prostate biopsy - Abstract October 15, 2013

Identifying barriers to patient acceptance of active surveillance: Content analysis of online patient communications - Abstract October 15, 2013

High-dose-rate prostate brachytherapy based on registered transrectal ultrasound and in-room cone-beam CT images - Abstract October 15, 2013

PSAP expression in a primary presacral neuroendocrine tumor: Potential for confusion with prostate cancer - Abstract October 15, 2013

Changes in fPSA level could discriminate tPSA flare-up from tPSA progression in patients with castration-refractory prostate cancer during the initial phase of docetaxel-based chemotherapy - Abstract October 15, 2013

Prostate histoscanning in clinically localized biopsy proven prostate cancer - An accuracy study - Abstract October 15, 2013

Clinical features and treatment strategies for older prostate cancer patients with bone metastasis - Abstract October 15, 2013

Metastatic prostate cancer in transsexual diagnosed after three decades of estrogen therapy - Abstract October 15, 2013

Dose-adapted salvage radiotherapy after radical prostatectomy based on an erMRI target definition model: Toxicity analysis - Abstract October 15, 2013

Comparative study of the oncologic results of the radical prostatectomy versus external beam radiotherapy (75.6Gy) combined with concomitant hormonotherapy for prostate cancer at intermediate risk of D'Amico - Abstract October 15, 2013

MR-guided biopsy of the prostate: Comparison of diagnostic specimen quality with 18G and 16G biopsy needles - Abstract October 15, 2013

Do margins matter? The influence of positive surgical margins on prostate cancer-specific mortality - Abstract October 15, 2013

Predictors of pathologic progression on biopsy among men on active surveillance for localized prostate cancer: The value of the pattern of surveillance biopsies - Abstract October 15, 2013

Improving plan quality and consistency by standardization of dose constraints in prostate cancer patients treated with CyberKnife - Abstract October 15, 2013

Influence of obesity on localized prostate cancer patients treated with radical prostatectomy - Abstract October 15, 2013

Variants at IRX4 as prostate cancer expression quantitative trait loci - Abstract October 12, 2013

Prediction of immune surveillance responsive metastatic prostate cancer in pelvic lymph node and emergence of surveillance unresponsive/resistant metastatic cells - Abstract October 12, 2013

Bone microenvironment-targeted manipulations for the treatment of osteoblastic metastasis in castration-resistant prostate cancer - Abstract October 12, 2013

TOOKAD(®) Soluble vascular-targeted photodynamic (VTP) therapy: Determination of optimal treatment conditions and assessment of effects in patients with localised prostate cancer - Abstract October 11, 2013

Page 1103 of 1435